Tranacix

TRANACIX® Line
2ml | 30g

10%TA Sterile Facial Solution
3%TA Cream SPF20
3%TA Day Cream SPF50+
3%TA Night Cream

TRANACIX® Sterile Facial Solution
Ampoules of 2ml – Box of 10 ampoules

10% Tranexamic Acid sterile facial solution, a revolutionary formula for skin tone imperfections. For Professional use.

Active ingredients
Tranexamic acid, an old molecule with a new life in dermatology. TA is an effective drug in the treatment of Melasma and other dermatological diseases.

Indications
The treatment of melasma is still the major indication. However, exist others indications with TA as a key active ingredient in its management: Rosacea, post-acne erythema, PIH.

Tranexamic acid is known as an oral medicine for treating melasma. Its rare but severe side effects when taken orally, such as pulmonary embolism, deep-vein thrombosis, myocardial or cerebrovascular infarction, make risky its systemic use in dermatology. When intradermal TA is used in office sessions combined with topical TA at home, it represents a new, safe and effective treatment to eliminate and attenuate Melasma.

Sterile Facial Solution with 10% Tranexamic Acid as the main active ingredient, a revolutionary formula for skin tone imperfections.

Directions for use
Professional use only. Convenient for use with:

• Dermaroller,
• Microneedling,
• Mesotherapy.

Best Protocol Recommendation:

• Concentration used: 10% TA
• Frequency of procedures: bimonthly (2xmonth)
• Duration of treatment: minimum 3 months, optimal 6 months.
• Integrated skincare treatment approach: On combination with TRANACIX® Cream (twice / thrice a day, in the morning /afternoon / at night) on the considered areas.

Targets
Dermatology | Aesthetic Medicine

Origin
Made in EU

TRANACIX® Cream SPF20
30g

Topical 3% TA Cream, a revolutionary formula for skin tone imperfections.

Active ingredients
Tranexamic Acid 3%.

Tranexamic Acid is a synthetic derivative of the amino acid Lysine and it has been used for a long time as a traditional hemostatic medicine since 1962. The first mention of TA in dermatology was in 1979 reported a very good result by using oral TA in Actinic Prurigo (Skin disorder due to sun exposure).
Later, TA was under study in dermatology and in 1998 demonstrated in vitro that TA could block melanogenesis.

Indications
Management of Melasma. Extended use with clinical data:

• Post Inflammatory Hyperpigmentation.
• Rosacea, Skin Redness.
• Acne-related Post-Inflammatory Erythema.

Properties
TRANACIX® – Melasma treatment aim:
Primarily on hyperpigmentation associated with melanogenesis and secondly on the underlying increase in vascular proliferation which can present as subclinical or clinical erythema and decreasing fibroblast growth factor and ultraviolet-light-induced proliferation of mast cells.

TRANACIX® with SPF (Sun Protection Factor) – In reality, sunscreen should be applied every day, even if it is overcast outside or you’re spending much of the day inside. UV radiation is not only present on a warm summer’s day but are also present and can damage skin when the weather is cool, or there is cloud cover.

TRANACIX® Day Cream with SPF 20 – In addition to the curative action of Tranexamic Acid, SPF 20 will have UV protective action against solar radiation on a normal sunny day. Therefore, the treatment involves twice-a-day application in the morning and at night.

Directions for use
On perfectly clean skin apply TRANACIX® Cream (twice / thrice a day, in the morning /afternoon / at night) on the considered areas. Slightly massage in order to make its absorption easier. Once perfectly absorbed, makeup is possible.

TRANACIX® Day Cream SPF50+
+
TRANACIX® Night Cream
30g

Full day protection 3% TA Creams, a revolutionary formula for skin tone imperfections.

TRANACIX® range includes two new products, whose active ingredient is 3% tranexamic acid in each formula, with similar efficacy.

This latter first displays an excellent activity on pigmentary spots, as well as a prevention as for attenuating and removing them. It also features an excellent activity on skin redness.

TRANACIX® Day Cream with SPF 50+ should protect your skin 50 times as long as your skin would be able to naturally protect itself. SPF 50+ blocks 98% UV (UV-B).
Therefore, it is recommended for day use, in conditions of intense sun exposure.

The treatment involves TRANACIX® Day Cream with SPF 50+ twice a day application, in the morning & in the afternoon and followed by TRANACIX® Night Cream at night.

Targets
Dermatology | Aesthetic Medicine

Origin
Made in France

Clinical evidences with SODERMIX® Cream:

Efficacy of 3% tranexamic acid was assessed in melasma in these clinical cases:

Clinical evidences with TRANACIX® Sterile Facial Solution

Ampoules 2ml. Convenient for professional use with Dermaroller, Microneedling and Mesotherapy.